Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Integrin alpha 4/CD49d Antibody (44H6), Janelia Fluor™ 646, Novus Biologicals™

Mouse Monoclonal Antibody
Supplier: Novus Biologicals NB10064903JF646
Description
Integrin alpha 4/CD49d Monoclonal specifically detects Integrin alpha 4/CD49d in Human samples. It is validated for Flow Cytometry, Immunohistochemistry, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen.Specifications
Integrinalpha4/CD49d | |
Monoclonal | |
Janelia Fluor 646 | |
50mM Sodium Borate with 0.05% Sodium Azide | |
ITGA4 | |
HOON pre-B leukemia cell line | |
0.1 mL | |
Primary | |
NB100-64903 recognizes CD49d, also known as Integrin alpha 4, which associates with either CD29 (integrin beta 1) or integrin beta 7. CD49d is a 150kD molecule, which may be cleaved to 80kD and 70kD fragments. It is expressed by lymphocytes, monocytes, eosinophils and thymocytes. VLA-4 mediates cell adhesion to VCAM-1 and fibronectin. 44H6 induces homotypic aggregation. | |
Store at 4°C in the dark. | |
IgG1 |
Flow Cytometry, Immunohistochemistry, Immunohistochemistry (Frozen), Immunohistochemistry (Paraffin) | |
44H6 | |
Flow Cytometry, Immunohistochemistry, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen | |
269C wild type, CD49 antigen-like family member D, CD49d, CD49d antigen, CD49Dantigen CD49D, alpha-4 subunit of VLA-4 receptor, IA4, integrin alpha 4, integrin alpha-4, integrin alpha-4 subunit, Integrin alpha-IV, integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor), MGC90518, very late activation protein 4 receptor, alpha 4 subunit, VLA-4 subunit alpha | |
Mouse | |
Protein A or G purified | |
Cancer, Cellular Markers, Cytoskeleton Markers | |
3676 | |
Human | |
Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction